HRSA 340B Prime Vendor Agreement

HRSA’s 340B Prime Vendor (PV), managed by Apexus Inc., in accordance with HRSA 340B Prime Vendor Agreement, Section VIII, Terms effective September 10, 2004, the Agreement will be extended, through the exercise of Option Year Three, by one year (September 10, 2008 through September 9, 2009). The 340B PV has brought significant value to participating 340B safety-net provider hospitals and clinics during the four years of the five year agreement with HRSA. Apexus continues to expand the value of the Prime Vendor for participants by 1) negotiating sub-ceiling discounts on over 2,800 brand and generic drugs averaging 16 percent below statutory ceiling prices; 2) securing contracts for drug wholesale distribution with 14 national, regional, and specialty distributors; 3) improving medication access for smaller clinics by providing alternative distribution options and costs by an average of 7 percent; and 4) negotiating discounts on other products and services such as vaccines, diabetic meters/strips, diagnostic test kits, prescription vials, and outpatient pharmacy technology solutions. THIS ANNOUNCEMENT IS NOT A NOTICE OF SOLICITATION.